Form 4 Tracker
Robert Charles Jahr

Director, Chief Executive Officer · 2 filings · Latest: Aug 14, 2026

Outlook Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
OTLK
Robert Charles JahrDirector, Chief Executive OfficerAug 14, 2026
Purchase
151,515151,515